A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Director – Global Medical Affairs Technology

Technical Product ManagementConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$187.4k - $253.6kIn-person

About the Job

Requirements

  • A bachelor's degree in Information Systems, Computer Science, Data Science, Engineering, Health Informatics, Business, or a related technical or business discipline is required.
  • At least 10 years of experience in life sciences technology, Medical Affairs technology, commercial or medical platform leadership, digital product management, or related roles in regulated environments is required.
  • Demonstrated experience owning enterprise product or platform roadmaps and lifecycle management for shared capabilities rather than one-off projects or localized solutions is required.
  • A strong understanding of Medical Affairs processes and capabilities, including field medical, medical insights, medical information, scientific communications, omnichannel engagement, KOL/HCP engagement, and/or real-world evidence, is required.
  • Experience with data platforms, integrations, analytics enablement, and data governance, and the ability to partner effectively with Data & AI and enterprise technology teams, is required.
  • The ability to define priorities, standards, KPIs, and governance mechanisms that drive measurable business outcomes, simplification, and reuse is required.
  • Stakeholder management and executive communication skills, including the ability to influence across Medical Affairs, Technology, Data & AI, Legal/Compliance, Privacy, Quality, and external partners in a matrixed global organization, are required.
  • Experience engaging vendors, managed service providers, and contractors to coordinate delivery across internal and external teams, without direct people-management accountability, is required.
  • Experience operating in biotech, pharma, healthcare, or another regulated industry, with a strong understanding of compliance, privacy, security, documentation, and auditability requirements, is required.

Responsibilities

  • Own the Medical Affairs technology strategy and portfolio as the primary technology leader and business partner to Global Medical Affairs, translating business priorities across field medical, medical insights, omnichannel engagement, medical information, scientific communications, KOL/HCP engagement, and real-world evidence into an enterprise-aligned technology roadmap.
  • Own product and platform lifecycle management for Medical Affairs technology capabilities, including roadmap, standards, architecture principles, lifecycle planning, and governance, ensuring platforms are scalable, compliant, reusable, and aligned with enterprise technology and data strategy.
  • Define and govern the Medical Affairs data strategy in partnership with Data & AI, including data ingestion, integration, reusable data assets, governed access, analytics enablement, and measurement frameworks supporting medical insights generation, longitudinal analysis, real-world evidence, and decision support.
  • Build the technology and data foundation linking content, interactions, and insights across MSL/MOSL engagement, scientific communications, medical information, medical web and digital channels, and broader omnichannel medical capabilities.
  • Reduce fragmentation, manual work, siloed reporting, and bespoke solutions across the Medical Affairs ecosystem while promoting shared platforms, standardized data products, and enterprise-aligned design patterns.
  • Partner on intake, prioritization, and cross-functional delivery for Medical Affairs technology investments, working with Medical Operations & Insights and other stakeholders to translate business needs into platform capabilities, roadmap decisions, and measurable releases that improve user experience, operational efficiency, and business outcomes.
  • Jointly define adoption, performance, and value-realization measures with Medical Operations & Insights, Data & AI, and business stakeholders by establishing KPIs, monitoring usage and platform health, using evidence to refine priorities and communicate impact, and ensuring investments deliver measurable value.
  • Govern operations, compliance, and vendor performance to ensure Medical Affairs platforms and data products are reliable, secure, auditable, and well-supported, with accountability for privacy, security, documentation, quality, service delivery, and partner performance.

Desired Qualifications

  • An advanced degree in life sciences, business, informatics, data, technology, or a related field is preferred.
  • Direct experience supporting Global Medical Affairs, Field Medical, Scientific Communications, Medical Information, or other scientific or evidence-based functions is preferred.
  • Experience with platforms and capabilities such as CRM, medical engagement tools, medical information/communications systems, digital publishing, KOL planning, content management, or medical web platforms is preferred.
  • Experience enabling AI-ready data products, knowledge management, analytics, or decision-support capabilities for Medical Affairs is preferred.
  • Experience supporting global organizations across regions, therapeutic areas, and country-specific regulatory or privacy requirements is preferred.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs